Order Article Reprints

Banerjee A, Cai S, Xie G, Li N, Bai X, Lavudi K, Wang K, Zhang X, Zhang J, Patnaik S, et al. A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition. Cancers. 2022; 14(9):2311. https://doi.org/10.3390/cancers14092311

Banerjee, Ananya, Shurui Cai, Guozhen Xie, Na Li, Xuetao Bai, Kousalya Lavudi, Kevin Wang, Xiaoli Zhang, Junran Zhang, Srinivas Patnaik, and et al. 2022. "A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition" Cancers 14, no. 9: 2311. https://doi.org/10.3390/cancers14092311

Banerjee, A., Cai, S., Xie, G., Li, N., Bai, X., Lavudi, K., Wang, K., Zhang, X., Zhang, J., Patnaik, S., Backes, F. J., Bennett, C., & Wang, Q.-E. (2022). A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition. Cancers, 14(9), 2311. https://doi.org/10.3390/cancers14092311